Enzymotec Ltd
ENZY
ENZY was delisted on the 10th of January, 2018.
2 hedge funds and large institutions have $2.35M invested in Enzymotec Ltd in 2013 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$1.59M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$868K |
Top Sellers
ENZY Hedge Fund Activity: Q3 2013 in Review
2 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Enzymotec Ltd (ENZY) for Q3 2013, worth a combined $2.35M.
Buyers outnumbered sellers: 2 funds opened new ENZY positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Driehaus Capital Management, opening a new position worth an estimated $1.59M.
- 2 institutional investors held Enzymotec Ltd (ENZY) as of Q3 2013, up from 0 in Q2 2013.
- Funds reported $2.35M of Enzymotec Ltd stock for Q3 2013.
- 2 funds opened new Enzymotec Ltd positions in Q3 2013 and 0 closed out, a net change of +2 holders.
- The largest Enzymotec Ltd buyer in Q3 2013 was Driehaus Capital Management, an estimated $1.59M added.
Based on aggregated 13F filings for Q3 2013.